Manulife Financial Q3 adjusted EPS beats analyst forecasts
Manulife Financial reported adjusted EPS of C$1.24 for the quarter ended September 30, above the C$1.18 analyst average, according to Earnings Summary citing LSEG data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Manulife Financial posted adjusted earnings of C$1.24 per share for the quarter ended September 30, up from C$1.16 a year earlier. The average estimate of 13 analysts was C$1.18, so the insurer came in ahead of expectations. Revenue reached C$10.95 billion and net income came to C$1.42 billion. On a reported basis, earnings per share were 82 cents. Figures come from an Earnings Summary report based on LSEG data.
why it matters
The shares rose 5.8% during the quarter and 28.8% so far this year. Meanwhile, the average earnings estimate fell about 1% over three months, and nine analysts cut their forecasts over the last 30 days. Recommendations remain mostly positive, with 10 buy ratings, 4 holds and 1 sell.
market impact
Manulife Financial shares: earnings above forecasts support the stock, though analyst estimates edged lower
- Manulife Financial shares pressure up — earnings above the consensus forecast support the stock
tags
instruments
sources
- Manulife Financial Corporation reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 09:49 UTC
- TOYOTA MOTOR CORPORATION reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:04 UTC
- TOYOTA MOTOR CORPORATION reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:25 UTC
- ArcelorMittal SA reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:36 UTC
- Haemonetics Corp reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:09 UTC
- PENN Entertainment, Inc. reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:16 UTC
- Southern Co reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:19 UTC
- Iovance Biotherapeutics Inc reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗